Starting longevity in childhood: what do/would you do with your kids?

#149

The Dietary Echo of Childhood Trauma: How Early Adversity Programs the Adolescent Immune System

A growing body of literature links early life stress (ELS) to chronic, low-grade systemic inflammation and increased mortality in adulthood. However, the behavioral intermediaries driving this phenotype have remained poorly understood. A breakthrough study demonstrates that severe stress experienced during infancy leaves a lasting behavioral imprint, manifesting as a highly pro-inflammatory diet more than a decade later, which directly drives peripheral inflammation.

The investigation focused on adolescents who spent their earliest months in resource-limited orphanages before being adopted into affluent families. Despite living in highly resourced environments for an average of 14 years, these previously institutionalized youth consumed significantly more pro-inflammatory foods than their non-adopted peers. This behavior is explained by the Neuro-Immune Network Hypothesis. Severe early deprivation alters neural circuits regulating reward processing, threat responses, and executive control. Consequently, individuals become biologically predisposed to seek out hyper-palatable, calorie-dense foods (high in refined sugars and saturated fats) as a form of physiological self-medication.

Crucially, this dietary pattern acts as a direct bridge to systemic inflammation. Using the Dietary Inflammatory Index (DII), researchers found that higher dietary inflammation scores directly predicted elevated levels of key circulating cytokines, specifically Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-alpha). Path analyses revealed that dietary choices statistically mediated the entire relationship between early institutional neglect and adolescent TNF-alpha levels. This creates a destructive feed-forward loop: early stress programs maladaptive eating habits, and the resulting pro-inflammatory diet perpetuates systemic low-grade inflammation, accelerating biological aging pathways.

The broader significance for longevity medicine is profound. It demonstrates that early environmental insult permanently calibrates metabolic and immune baselines, which cannot be entirely erased by subsequent socioeconomic or environmental enrichment. However, because diet is a modifiable behavioral lever, it presents an actionable therapeutic target to interrupt the translation of childhood trauma into adult disease.

Actionable Insights

For longevity biohackers, clinicians, and individuals managing historical trauma, the take-home message is clear: mitigating historical ELS requires strict, deliberate down-regulation of the Dietary Inflammatory Index (DII).

The paper demonstrates a powerful, quantifiable treatment effect:

  • Previously institutionalized youth exhibited a significantly higher mean DII score of 1.97 compared to 1.19 in controls (p = 0.003).

  • Across the cohort, dietary inflammation directly scaled with peripheral cytokine levels. Multiple regression analyses revealed that the standardized effect size (Std. B) of DII predicting TNF-alpha was 0.232 (p = 0.001), and for IL-6 was 0.168 (p = 0.027). Every unit increase in DII score increased unstandardized log-transformed TNF-alpha by 0.318 pg/ml.

To offset this biological trajectory, individuals should aggressively implement anti-inflammatory dietary architectures, such as the Mediterranean or strict plant-based diets, which emphasize omega-3 fatty acids, polyphenols, and high fiber. Global databases show DII scores can be driven as low as -8.87. Given that dietary inflammation fully mediates the path to upstream inflammatory initiators like TNF-alpha, driving the DII into negative territory offers a direct, non-pharmacological mechanism to lower the systemic chronic inflammation that underpins cardiovascular disease, type 2 diabetes, and neurodegeneration.

Source:

  • Open Access Paper: Inflammatory diet mediates the relationship between early life stress and inflammation in adolescents
  • Institutions: Center for Cognitive and Brain Health, Northeastern University, Boston, MA; Institute of Child Development, University of Minnesota, Minneapolis, MN; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • Journal Name: Brain, Behavior, and Immunity.
  • Impact Score: The impact score (CiteScore/Journal Impact Factor) of this journal is approximately 8.8. Evaluated against a typical high-end range of 0–60+ for top general science journals, this is a High impact journal, representing a premier tier for psychoneuroimmunology and systemic inflammation research.
1 Like
#150

Medical Education is Failing the Childhood Trauma Test

A systematic review reveals that while American medical training programs are expanding their curricula on Adverse Childhood Experiences (ACEs), the underlying educational interventions are methodologically weak, brief, and heavily reliant on unreliable trainee self-assessments. The severe lack of objective testing and longitudinal tracking means future physicians remain poorly equipped to mitigate the chronic inflammatory cascades driven by early life trauma.

Adverse Childhood Experiences (ACEs)—encompassing abuse, neglect, and household dysfunction—affect nearly two-thirds of the United States population. From a physiological standpoint, this early trauma is not merely a psychological scar; it is an upstream driver of systemic biological decay. Prolonged childhood stress dysregulates the sympathetic nervous system, triggers chronic cellular inflammation, and alters neurodevelopment. This state of permanent hyper-vigilance exhibits a strict dose-dependent relationship with adult metabolic collapse, depression, and severe chronic diseases.

Despite this profound impact on adult health and longevity, a systematic review by Fairchild et al. (2026) reveals that the medical establishment’s approach to training physicians on trauma-informed care is superficial. Out of 608 unique studies screened, only 15 empirical interventions in the US medical education pipeline met the inclusion criteria.

The core issue is a systemic lack of educational rigor. The median time dedicated to teaching future frontline physicians about this massive health driver is a mere 2.5 hours. Furthermore, two-thirds of these programs rely on passive, lecture-based formats. While 86.7% of the studies claimed to show post-intervention improvements in ACEs knowledge, only 20% actually measured this objectively through standardized tests or clinical skill evaluations. The vast majority of the literature relies on asking medical students and residents if they feel more confident. In medical education, self-assessment routinely leads to massive overestimations of actual competence. Consequently, the current pipeline produces clinicians who are aware that trauma impacts longevity, but who lack the verified, objective skills to screen, de-escalate, or treat it in real-world clinical environments.

Actionable Insights

For healthcare professionals, biotech entrepreneurs, and longevity practitioners, the gaps identified in this paper yield immediate, practical directives:

  • Implement Standardized, Forced Clinical Workflows: Do not rely on passive clinician education to change medical outcomes. The data shows that simply educating physicians yields no statistical change in their actual comfort or screening likelihood. However, when a physical, standardized screening tool is actively integrated into clinical operations, objective screening compliance can skyrocket from an absolute baseline of 0% to 60%.

  • Acknowledge the Self-Assessment Trap: Trainees and clinicians cannot accurately gauge their own trauma-informed capabilities. Objective evaluation metrics (such as multiple-choice quizzes or standardized patient simulations) must be utilized to verify competence.

  • Prioritize Personal ACE Score Evaluation: For individuals optimizing their own longevity, calculating your personal ACE score is a highly practical first step. Understanding this score provides an objective framework for personalized trauma-informed self-care and helps identify personal health trajectories.

Context & Impact Evaluation

#151

Thanks @RapAdmin for keeping this thread updated.

Yet again, it’s amazing how many things are not coming down to “traditional” health, but to mental health, wellbeing, trauma etc. I think this has been greatly overlooked for a long time, and it’s nice to see lots of new evidence coming out.

As a university professor, I see lots of 18-25 year olds, and many of them do basically seem traumatised. You give them the smallest compliment or some dedicated attention and they’re so surprised and appreciative. No idea what sort of parents they had :wink:

4 Likes
#153

It’s in the Blood: A Congo Basin Village Shows a Father’s Care — and His Quarrels — Leave Molecular Fingerprints on His Children

In a remote fishing-farming community in the Republic of the Congo, researchers found that how peers rated a father’s caregiving and marital conflict was statistically associated with patterns of DNA methylation in his children’s blood — and that the caregiving-linked marks tracked with the children’s physical growth. The work extends the “biological embedding” hypothesis beyond the usual Western samples, but it is small, cross-sectional, and correlational.

For two decades, a central idea in developmental biology has been that early family life gets “written” into the body at a molecular level — a process called biological embedding. The dominant tool for reading those marks is DNA methylation (DNAm), chemical tags that sit on the genome and can shift in response to the environment. Almost all of this work has been done in wealthy, Euro-American populations, and almost all of it has measured mothers, not fathers.

This preprint pushes into genuinely new territory on both counts. Working with 54 children from 17 Bandongo families in the rainforest of northern Congo — a non-market, pathogen-heavy subsistence society — the team asked whether two kinds of family dynamics left a methylation signature in children’s blood: negative (parental conflict) and positive (a father’s direct hands-on care and his indirect care, meaning food and resource provisioning). Crucially, the family ratings did not come from surveys but from other fathers in the village, ranking each other using a photo array — a culturally appropriate “peer-ranking” method.

Scanning roughly 46,000 co-methylated regions of the genome, they flagged eleven regions linked to parental conflict and five linked to paternal care. One conflict-associated region cleared the strictest statistical bar, sitting in TMEM86A, a gene tied to lipid and energy metabolism. Others fell in or near genes involved in inflammation (TOLLIP) and development.

The more interesting move came next. Using path models, the team showed that the caregiving-linked methylation — but not the conflict-linked methylation — tracked with the children’s actual physical condition (skinfold thickness and peer-rated health), with moderate-to-large statistical strength. They also found that families with more children showed methylation patterns running in the opposite direction to those produced by conflict, raising the speculative possibility that siblings buffer family stress.

The “big idea” is one of convergence: despite a radically different culture, economy, and ecology, the genes and biological themes implicated here — stress, immunity, development — echo what has been seen in Toronto, Wisconsin, and the UK. That cross-cultural similarity is the paper’s strongest contribution.

The cautions are equally large. With only 17 independent families driving the exposure measure, this is a statistically underpowered, observational snapshot. It cannot establish cause, and a liberal error threshold means several “hits” may be noise. It is a provocative map, not a verdict.

Actionable Insights

This is an anthropological epigenetics study of children, not a personal longevity protocol. The honest take-home messages are indirect:

  1. The relational/provisioning environment is biologically measurable. Children of fathers ranked higher on caregiving showed methylation patterns that tracked with better physical condition. Effect magnitude: standardized path coefficients of |B| ≈ 0.44–0.56 (moderate-to-large by Cohen’s convention) linking care-associated methylation to skinfold thickness and peer-rated health.
  2. Conflict-linked marks did NOT predict child health here — consistent with prior null findings in the same cohort — suggesting DNAm at these loci is a correlate of stress exposure, not necessarily a causal mediator of harm.
  3. “Dose” is small at the population level. The most robust hit showed a methylation difference of only ~3.7 percentage points (Δβ = 0.037) across the high-versus-low conflict contrast — biologically plausible but modest.

For the longevity reader, the transferable principle is unchanged from prior literature: psychosocial environment imprints on the epigenome early, and provisioning/care quality appears protective.

Source:

#154

Neurostructural Embedding of Systemic Stress: A Brain-Wide Association Analysis of Childhood Environments

A massive brain-wide association study demonstrates that childhood socioeconomic environments are the dominant predictors of individual variations in human brain structure and functional connectivity, eclipsing the impacts of both cognition and mental health. These structural alterations map directly onto the brain’s sensorimotor and arousal networks, revealing a distinct neural signature of chronic environmental stress.

Human neuroimaging has long struggled to map robust, reproducible relationships between brain architecture and individual behavioral phenotypes. In a definitive attempt to rank the real-world forces sculpting the human psyche, a study by Marek et al. analyzed 649 distinct phenotypic measures against the structural and functional brain scans of thousands of children aged 9 to 10. The data reveals a clear, unvarnished truth: the socioeconomic context of a child’s upbringing is the single most powerful non-biological factor altering the macroscale organization of the developing brain.

Socioeconomic status (SES)—a composite of neighborhood opportunity, family income, parental education, and school resources—overwhelmingly dominated the highest-ranked brain associations. Out of the top 40 strongest correlations identified across the entire phenome, SES variables accounted for 37 of the variations in functional connectivity and 35 of the variations in cortical thickness. This structural footprint was subsequently replicated in an independent adult cohort and remained completely independent of genetic ancestry, confirming that the variations are driven by the material realities of the childhood environment rather than hereditary predispositions.

Intriguingly, these neurostructural variations were not concentrated in higher-order cognitive regions. Instead, the structural differences localized heavily within the sensorimotor cortex—areas responsible for processing sensory inputs and motor outputs. These exact regions overlap with the neural circuitry that regulates systemic arousal, wakefulness, and physiological activation. The data strongly indicates that lower socioeconomic environments embed themselves biologically by forcing the brain into a state of chronic, sustained alert. Upstream lifestyle stressors frequently tied to lower SES, such as restricted sleep duration and elevated screen time, mapped onto these identical sensorimotor nodes.

Ultimately, this research reframes how we view cognitive development and neural healthspan. It demonstrates that standard brain-cognition models become highly inaccurate when they fail to account for background socioeconomic status, largely because traditional neuroimaging cohorts have been skewed toward affluent populations. While the developing brain retains significant adaptive plasticity, these findings prove that environmental stress physically molds the sensory and regulatory foundations of the central nervous system before an individual even hits adolescence.

Actionable Insights

For clinicians, biotech professionals, and longevity biohackers, this paper provides a stark reminder that systemic physiological strain overrides micro-optimized cognitive protocols. Because environmental volatility shapes the brain via autonomic arousal networks, direct interventions must prioritize stabilizing the body’s stress response and sleep architecture. The study specifically links lower sleep duration and high screen time to negative alterations in sensorimotor functional connectivity. Therefore, rigorous sleep optimization and the mitigation of nocturnal sensory overstimulation are foundational to preserving cortical integrity.

Effect Size and Variance Analysis

To understand the real-world magnitude of these findings, look directly at the variance metrics. The paper notes that even though socioeconomic status is the strongest phenotypic variable in the study, 84% or more of the variation in brain measures was not explained by socioeconomic status.

This means that SES accounts for a maximum of 16% of the total variance in cortical thickness and functional connectivity. In the landscape of human neuroimaging, an effect size explaining up to 16% of structural variance is extraordinarily large. However, from an optimization standpoint, it reveals that 84% of your neurostructural fate is determined by other factors, including direct biological interventions, targeted behaviors, sleep hygiene, and autonomic nervous system regulation. Early environment shapes the baseline, but it does not dictate final neurological capacity.

Source:

  • Paywalled “Perspective”: Childhood environments shape the brain, June 11, 2026
  • Institutions: Penn Lifespan Informatics and Neuroimaging Center; Lifespan Brain Institute of Penn Medicine and Children’s Hospital of Philadelphia; Department of Psychiatry, University of Pennsylvania.
  • Country: United States.
  • Journal Name: Science.
  • Impact Evaluation: The impact score of this journal is 44.7, evaluated against a typical high-end range of 0–60+ for top general science, therefore this is an Elite impact journal.
1 Like
#155

Nature Loads the Gun, Nurture Pulls the Trigger — Independently: Sweden’s 2.7-Million-Person Ledger on What Really Drives Schizophrenia and Bipolar Disorder

Using Swedish national registers covering everyone born from 1973 to 1998, researchers quantified how inherited family risk and early-life environmental exposures jointly shape the odds of developing schizophrenia (SCZ) or bipolar disorder (BD). They found that a multi-generational genetic risk index and modifiable exposures — chiefly childhood adversity and substance use — each raise risk substantially, but do so largely independently of one another, with little evidence that genes amplify environmental harm or vice versa. Genetic risk was steeper for schizophrenia (roughly 9x for the top risk group) than bipolar disorder (roughly 6x), while population-level modeling suggested that eliminating substance use or childhood adversity could theoretically prevent up to a fifth of cases.

For decades, psychiatry has repeated a comfortable slogan: mental illness arises from “genes and environment interacting.” This study, drawing on one of the most complete population datasets on Earth, delivers a more uncomfortable and more precise message. The interaction may be weaker than assumed. Instead, inherited risk and life exposures appear to stack additively, each contributing its own quota of risk on largely separate tracks.

The team built family genetic risk scores (FGRS) — an aggregate estimate of inherited liability computed from the diagnoses of up to four degrees of relatives (an average of 22 relatives per person), weighted by shared DNA, relatives’ age, and shared household. This is not a blood-test genotype; it is a statistical portrait of a family’s psychiatric history spanning generations. They then matched 3,057 schizophrenia cases and 15,029 bipolar cases to unaffected controls and asked how genetic and environmental risk combined.

The genetic gradient was stark. Individuals in the top fifth of family risk carried roughly nine times the odds of schizophrenia and six times the odds of bipolar disorder compared with people who had no affected relatives. Curiously, this genetic signal was stronger for schizophrenia even though the two disorders are thought to be similarly heritable — an unresolved puzzle the authors flag but cannot explain.

The headline for prevention is environmental. Childhood adversity (parental death, incarceration, separation, substance use, or abuse) and substance use emerged as the two most impactful modifiable factors. Crucially, their effects barely moved when genetic risk was controlled for, and vice versa — evidence that these are not merely genetic effects in disguise. In population terms, the authors estimate that removing substance use could avert about 18 percent of schizophrenia cases, and removing childhood adversity about 20 percent of bipolar cases.

The catch, which the authors state honestly, is that these population attributable fractions assume clean causation. In reality, substance use may partly be an early symptom rather than a cause, and childhood adversity is entangled with a parent’s own illness. When the team adjusted for childhood socioeconomic status, the adversity signal for schizophrenia nearly halved — a warning that “modifiable” is doing heavy lifting.

Actionable Insights

Be clear-eyed: this is a population-epidemiology paper about serious mental illness. Its take-home messages are structural and preventive, and the effect sizes are for developing SCZ/BD.

The two levers the data support:

Substance use. At the individual exposure level, a substance use diagnosis was associated with an IRR of 6.21 for schizophrenia and 4.84 for bipolar disorder — meaning roughly 6x and 5x elevated odds. These are among the largest environmental signals in the psychiatric literature. Population attributable fraction: SCZ 18.3 percent, BD 13.2 percent. Interpretation caveat below.

Childhood adversity (ACEs). IRR 1.65 (SCZ) and 1.74 (BD) — a 65 to 74 percent increase in odds. PAF: SCZ 14.1 percent, BD 19.8 percent. But adjusting for childhood socioeconomic status collapsed the SCZ figure to 8.6 percent, so treat the modifiable fraction as an upper bound.

For a clinician or health-conscious reader, the defensible message is narrow: avoiding a substance use disorder and mitigating adverse childhood environments are the highest-leverage points, and they act on top of, not merely through, inherited risk. The IRRs also mean that eliminating one exposure cannot cancel a high genetic baseline — it modifies it.

Context / Source

2 Likes
#156

Track your children’s blood pressure during the teenage years: Your Rising Teenage Blood Pressure Is a Bigger Time Bomb Than Your Adult Reading

1 Like
#157
3 Likes
#158

People who consumed less sugar during the first 1,000 days after conception may be significantly less likely to develop Alzheimer’s disease later in life, according to a new study published in the journal npj Aging .

The study:

Early-life sugar rationing, brain aging, and long-term neurodegenerative and psychiatric health outcomes: a population-based natural experiment study

https://www.nature.com/articles/s41514-026-00452-z

2 Likes
#159

Screenshot 2026-08-06 at 2.27.07 PM
Screenshot 2026-08-06 at 2.27.07 PM946×794 91.4 KB

Related paper:

2 Likes
#160

Blame the Divorce, Miss the Cause: Why the Split Itself May Not Be What Scars Kids

Using four years of pooled U.S. survey data on more than 128,000 adults, researchers confirmed that people whose parents divorced during their childhood, or who were born to unmarried parents, report more adult depression and recent mental distress than people whose parents stayed married. The twist is what happened when the team accounted for other hardships that tend to travel with divorce, above all a parent’s own mental illness and substance use. Once those were included, the link between the marital event itself and adult mental health largely vanished. The signal that looked like divorce turns out to be mostly the company divorce keeps.

For decades, a familiar worry has hung over separated families: that the divorce itself leaves a lasting mark on children that follows them into adulthood. A new analysis in Psychiatry Research puts a large and careful dataset behind that worry, and then complicates it in a way that matters for anyone thinking about how early life shapes long-term health.

The team, led by Mary Kate Schilke and Esme Fuller-Thomson at the University of Toronto with Philip Baiden at the University of Texas at Arlington, drew on the U.S. Behavioral Risk Factor Surveillance System, a rolling national health survey. From the 2021 to 2024 waves they assembled 128,264 adults, deliberately excluding anyone who reported childhood sexual or physical abuse so that those severe traumas could not muddy the picture. They then compared three groups: adults whose parents stayed continuously married, those whose parents divorced before they turned 18, and those born to unmarried parents.

At first glance the pattern is exactly what you would expect. Lifetime depression was reported by 14.1 percent of the continuously-married group, rising to 19.2 percent among children of divorce and 18.7 percent among children of unmarried parents. Frequent mental distress in the past month showed the same tilt, climbing from 8.5 percent to 13.6 and 16.3 percent respectively. On their own, these gaps look like a clear cost of family breakup.

The heart of the paper is what came next. The researchers layered in other adverse childhood experiences one at a time, then in clusters. A single factor did most of the work. Accounting for parental mental illness cut the divorce-to-depression association by 68 percent. Parental substance use knocked off roughly another half on its own. Put the two together and the association was no longer statistically distinguishable from zero. Add socioeconomic and health-behaviour factors on top, and it disappeared entirely.

The interpretation the authors reach, cautiously, is that the divorce event is not the active ingredient. Divorce rarely arrives alone. One in three children of divorce in this sample also lived with parental substance use, one in five with parental mental illness. These co-travelling adversities, several of them partly heritable, appear to be doing the damage that divorce gets blamed for.

The practical upshot is a shift in where to aim. If you want to protect a child’s long-term mental health, the target is the constellation of family adversity, especially untreated parental mental illness and addiction, not the marriage certificate. It is an unusually large study making an unusually humble point: the obvious culprit is mostly a bystander.

Actionable Insights

Keep one caveat in front of you the whole time: this is a snapshot survey of adults recalling their childhoods, not an experiment, so it can show links but cannot prove cause. With that said, here is what you can actually use.

The headline number that survives scrutiny is not about divorce, it is about parents. A child living with a parent who has untreated mental illness or a substance-use problem carries the real elevated risk. So if that describes a household you can influence, the highest-value action is getting the parent into treatment, because that is the factor the data keep pointing to.

How big is the raw effect before adjustment? Modest. Children of divorce had a depression rate of 19.2 percent versus 14.1 percent for the married group. That is a 5.1 percentage-point absolute increase, or a relative risk of about 1.36, meaning roughly 36 percent higher likelihood. In plain terms, you would need about 20 children of divorce for one extra depression case beyond the married-parent baseline. Translated into a standardized effect size, the odds ratio of 1.41 corresponds to a Cohen’s d of about 0.19, which sits in the small range. The strongest raw signal in the whole paper, distress among children of unmarried parents (16.3 versus 8.5 percent, roughly double the odds), still only reaches a Cohen’s d near 0.36, a small-to-moderate effect. And every one of these effects shrinks toward nothing once parental mental illness and addiction are accounted for. The take-home: the family environment around a child matters far more than whether the parents’ relationship carries a legal label.

Context and Source

  • Open Access Paper: Long after the split: The association between parental divorce and mental health in adults.
  • Authors and institutions: Mary Kate Schilke (Tyndale University and Toronto Metropolitan University, Canada), Philip Baiden (University of Texas at Arlington, United States), and Esme Fuller-Thomson (University of Toronto, Canada).
  • Journal: Psychiatry Research (Elsevier).
  • Impact evaluation: The impact score of this journal is 5.1 (2025 Journal Impact Factor; CiteScore 8.7), evaluated against a typical high-end range of 0 to 60+ for top general-science and flagship clinical journals, therefore this is a Medium impact journal.
1 Like
#161

How early life stress leads to long term stress hypersensitivity later in life

Researchers at Princeton, Washington University in St. Louis, and Mount Sinai show that early-life stress in mice leaves a lasting chemical tag, H3K4me1, on the DNA-packaging proteins of neurons in the ventral tegmental area, a core dopamine hub. The tag is written by an enzyme called SETD7, which is elevated after stress. This tagging does not by itself change behavior. Instead it primes the circuit, so that a later stress in adulthood produces an exaggerated genetic, electrical, and behavioral response. Adding the enzyme artificially reproduces stress vulnerability, and removing it protects against it. The work offers a concrete molecular mechanism for why childhood adversity raises lifelong risk for depression and anxiety.

One of the most reliable findings in mental-health research is also one of the hardest to explain: people who face serious adversity as children are more vulnerable to depression, anxiety, and substance-use disorders decades later. The stress does not simply pass. Something gets stored. This study proposes what that something is at the molecular level, and where it lives in the brain.

The team focused on the ventral tegmental area, or VTA, a small cluster of dopamine-producing neurons that sits at the center of the brain’s motivation and reward machinery. Using a mouse model in which pups experience stress between postnatal days 10 and 17, the researchers first ran an unbiased survey of more than 200 chemical modifications on histones, the spool-like proteins that DNA winds around. Roughly three quarters of the changes they found pushed chromatin toward a more open, ready-to-read state. One modification stood out: monomethylation of histone H3 at lysine 4, written in shorthand as H3K4me1, a mark associated with primed enhancers, the genomic switches that sit poised to activate genes.

They then traced the mark back to its author. Of a dozen or more candidate enzymes, only one, SETD7, was consistently increased after early stress. SETD7 is unusually clean in what it does: it adds a single methyl group to H3K4 and nothing more, which made it an ideal tool to test cause and effect.

Here the study earns its central claim. Using engineered viruses, the researchers turned SETD7 up in the developing VTA of otherwise normal mice, and turned it down in stressed mice. Turning it up did nothing on its own. But when those mice met a stressor in adulthood, their dopamine neurons fired more, their gene-expression response flipped from mostly shutting down to actively ramping up, and their behavior tipped toward the socially withdrawn, anxious profile that marks stress susceptibility. Turning SETD7 down in early-stressed mice did the reverse, largely restoring resilience.

The big idea is epigenetic priming. Early adversity does not necessarily damage the circuit outright. It leaves a molecular bookmark that changes how the circuit will respond the next time life gets hard. That reframes childhood adversity as a latent, and potentially reversible, molecular state rather than fixed damage. The same logic hints that priming might one day be nudged toward resilience, though that remains a long way from the clinic.

Actionable Insights

Be honest about what this paper is: a mouse study of brain biology. It does not test a supplement, a diet, a drug you can buy, or a longevity protocol. There is no lifestyle lever here that a reader can pull tomorrow, and anyone selling a SETD7 or H3K4me1 hack based on this paper is ahead of the evidence.

What it does offer is a strong, mechanistically grounded reinforcement of a public-health message: early-life adversity is biologically encoded, and the encoding sits in the dopamine reward system that governs motivation and mood. The take-home for adults with difficult childhoods is that heightened stress reactivity is a real, physical predisposition, not a character flaw, and that later stressors are the trigger that converts predisposition into symptoms. That argues for taking adult stress management seriously as prevention, especially for this group.

On magnitude, the manipulations that mattered were large in the mouse. Boosting the enzyme roughly sextupled the odds of becoming stress-susceptible (50 percent of enzyme-boosted mice became susceptible versus about 8 percent of controls, a relative risk near 6). Blocking it cut susceptibility from 85 percent down to 33 percent in previously stressed mice, a reduction of about 61 percent. Those are big biological swings, but they are in animals and in engineered conditions, not in people. [Confidence: Medium]

Context and Source

  • Open access Paper: Early-life stress alters H3K4me1 in VTA to prime stress sensitivity.
  • Authors: Hye Ji J. Kim, Luke T. Geiger, Julie-Anne Balouek, and colleagues, with senior authors Ian Maze, Meaghan C. Creed, and Catherine Jensen Peña.
  • Institutions and country: Princeton Neuroscience Institute (Princeton University); Washington University in St. Louis; Icahn School of Medicine at Mount Sinai and Howard Hughes Medical Institute. All United States.
  • Journal: Neuron (Cell Press, an imprint of Elsevier). Volume 115, dated January 6, 2027 (published online 2026).
    Impact evaluation: Neuron’s Journal Impact Factor is approximately 15 (2024 Journal Citation Reports), with a Scopus CiteScore near 25. The impact score of this journal is approximately 15, evaluated against a typical high-end range of 0 to 60-plus for top general-science and flagship journals, therefore this is a High impact journal.
1 Like
#162

Pushed that WWII study through my Claude analysis prompt:
Bottom line: A large study of British adults found that people whose first two years of life fell under wartime sugar rationing were somewhat less likely to be diagnosed with dementia, Alzheimer’s, depression, and anxiety decades later, and had brains that looked very slightly “younger” on scans. But the effect on dementia, in real-world terms, is small — roughly one or two fewer cases per thousand people — and the study can’t prove sugar was the cause, because almost everything about British life was changing in 1953. You should keep following the sensible existing advice to limit added sugar for pregnant women and babies, but this study alone is no reason to panic about a toddler’s birthday cake.

2 Likes
#164

Related: Early Life Stress Pushes Biological Age Up 38 Percent Before Any Sign of Illness

#165

MotherObesityChildren
MotherObesityChildren1920×1072 318 KB

Maternal Obesity Leaves Marks on Eggs That Resurface in Daughters and Granddaughters Raising Their Risks of Obesity and Metabolic Disorders.

Chinese researchers report that diet-induced obesity in female mice adds DNA methylation at a small set of metabolic genes in their eggs, notably Hnf1a, Thra and Pdk4. The marks are erased after fertilisation, then reappear after birth in the daughters’ liver, muscle and eggs, alongside altered gene activity and poorer glucose handling. Writing the same marks directly onto eggs from lean mice, using an epigenome editor, was enough to produce mild glucose abnormalities in daughters but not sons. A small set of human eggs showed a loosely similar pattern.

Researchers have long known that children of mothers with obesity face a higher risk of metabolic disease. In mice, part of that risk travels through the egg itself, not only through the womb or milk. What nobody had pinned down was the physical carrier. A team led from Nanjing Medical University now reports a candidate: methyl groups, small chemical tags attached to DNA, sitting at a handful of metabolic genes in the egg.

The researchers fed female mice a high-fat diet for eight weeks, then read the methylation pattern across the genome of their eggs. Overall methylation barely moved (39.05 percent versus 39.37 percent). The differences were local. Some 940 regions changed, and 51 sat near genes with known metabolic roles. Three stood out because the change reappeared in daughters and granddaughters. They were Hnf1a, a control gene in the liver; Thra, a thyroid hormone receptor; and Pdk4, an enzyme that helps decide whether muscle burns sugar or fat.

The odd part is how the mark travels. After fertilisation the tags were wiped clean, as developmental biology says they should be. They stayed absent in the embryo and in the daughter’s early germ cells. Then, after birth, they came back in the daughter’s liver or muscle and in her own maturing eggs. A separate mark on the proteins that package DNA, called H3K36me2, remained at those spots during the gap. The team proposes it acts as a bookmark showing the cell where to rewrite the methylation. That part is an association, not proof.

The strongest experiment skipped diet altogether. Using a disabled CRISPR protein fused to a methyl-adding enzyme, the team wrote extra methylation onto either Hnf1a or Pdk4 in eggs from lean mice. They fertilised the eggs in a dish and transferred the embryos to surrogate mothers. Daughters from Pdk4-edited eggs cleared a glucose injection more slowly. Daughters from Hnf1a-edited eggs produced more glucose when given pyruvate, a sign of an overactive liver. Sons showed nothing. Body weight, fasting glucose and insulin sensitivity were normal, so these are mild defects revealed only under challenge, not diabetes. For Pdk4, the trait also appeared in the next generation of females.

Finally, the group examined 22 immature eggs donated by 12 women undergoing IVF. The human counterparts of the Hnf1a and Thra regions carried more methylation in eggs from the five women with higher body mass index. The sample is tiny and no statistics are reported. The regions were also already heavily methylated in lean women, so the resemblance to the mouse is loose.

The significance is that a specific, engineered epigenetic mark in an egg has been shown to be sufficient to alter offspring metabolism. The study does not show that these marks are necessary for the effect of maternal obesity. Nor does it show that losing weight before conception removes them. The authors describe the preconception period as a window for intervention. That is a reasonable hypothesis that this paper did not test.

Actionable Insights

The practical message is for women planning pregnancy. Metabolic health before conception may influence a daughter’s glucose regulation through the egg, independent of pregnancy itself. In mice, a single edited mark raised daughters’ peak blood glucose after a glucose injection by roughly 47 percent (about 17 versus 12 mmol/L), with levels back to normal within 90 minutes. A second mark raised peak glucose after a pyruvate injection by roughly 17 percent. In statistical terms these are large effects, about 1.4 standard deviations. That means a typical affected mouse scored worse than roughly 90 percent of controls. However, the groups were small (6 to 10 animals), so the true size could be far smaller.

The effects were also mild. Fasting glucose, body weight and insulin sensitivity were unchanged. Sons were unaffected.

For daughters of mothers who had obesity, this is not a verdict. If anything it supports routine glucose screening and standard metabolic hygiene.

Whether weight loss, exercise or medication before conception reverses the egg marks was not examined. The human data (22 eggs from 12 women) are too thin to guide any decision.

Context and Source

  • Paywalled Paper: Maternal obesity imprints methylation marks in oocytes to drive intergenerational metabolic dysfunction
  • Institutions: State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University (lead). Collaborators are at Nanjing University of Chinese Medicine, the Women and Children’s Hospital of Chongqing Medical University, Fudan University, and Changzhou Maternal and Child Health Care Hospital.
  • Country: China
  • Journal: Nature Metabolism, published online 2 October 2026.
  • Impact evaluation: The impact score of this journal is 20.8 (2024 Journal Impact Factor, released June 2025), evaluated against a typical high-end range of 0 to 60+ for top general science, therefore this is a High impact journal.
1 Like
#166

StressBrain
StressBrain2752×1536 510 KB

Why High Stress Events and Environments during Childhood Result in Frequent Stresses for the rest of a Person’s Life

Mount Sinai researchers used whole-brain activity mapping in mice to ask why one bad experience makes the next one feel worse. They found that a small, understudied region, the anterior hypothalamic nucleus (AHN), becomes more reactive after a severe stressor. Previously stressed mice recruited about 36 percent of AHN neurons in response to a later loud noise, versus 24 percent in unstressed mice. Silencing these neurons, or the amygdala fibres feeding them, reduced fear behaviour, and artificially activating them increased it. The effects on behaviour are large by statistical convention, but they rest on one behavioural measure, in young mice, with no human data and no drug target.

People who have lived through severe stress tend to react more strongly to later stressors, even mild ones. This “stress sensitization” raises the risk of PTSD and depression. Where it is stored in the brain has been unclear, because most research has looked in the same few places: amygdala, prefrontal cortex, hippocampus.

A team led by Zachary Pennington and Denise Cai at the Icahn School of Medicine at Mount Sinai took a different route. They gave mice ten footshocks, waited ten days, then played a loud burst of noise. Shocked mice froze about twice as long after the noise as mice that had never been shocked. The researchers then cleared the animals’ brains to make them transparent and counted active cells across 452 regions.

The cortex of previously stressed mice was quieter. Two deep regions were more active. One was the AHN, a hypothalamic nucleus better known for temperature control, sleep and aggression. Its activity was also more tightly correlated with a cluster of threat-related regions, including most of the amygdala.

To see what AHN cells respond to, the team mounted miniature microscopes on the heads of mice and watched hundreds of inhibitory neurons fire. The cells responded to shocks and loud sounds, more strongly to stronger ones, and went quiet when a thirsty mouse drank water or sugar solution. That pattern suggests the cells track how bad something is, not merely how attention-grabbing it is.

The key finding concerns what prior stress changed. Individual responsive neurons did not fire harder. Instead, more neurons joined in. The share of cells responding to the noise rose from roughly a quarter to more than a third.

The team then tested cause and effect. Switching AHN neurons off with light during the footshocks cut freezing during the shocks and in later memory tests. Switching them off later, when the mice were returned to the shock chamber or heard the noise, also cut freezing, and the behaviour returned within moments of the light going off. Chemically activating the cells made mice freeze about ten times longer after the noise. Finally, silencing amygdala nerve endings inside the AHN during the noise reduced freezing.

Manipulating the AHN did nothing to a standard anxiety test, and activating it without a stressor did not cause freezing. The AHN therefore looks like an amplifier for threats that are actually present.

Some of the paper’s wording outruns its data. The abstract says silencing amygdala inputs “abolished” sensitized responses. The figure shows a reduction of about nine percentage points, with no unstressed group in that experiment to show what a non-sensitized response would be. The work was done in young mice, with freezing as the only behavioural readout, and no stress hormone measurements.

Actionable Insights

  1. Prior severe stress roughly doubled the fear response to a later, unrelated mild stressor: freezing rose from about 22 to about 47 percent of the time. In statistical terms that is a “large” effect (Cohen’s d near 1.0, meaning the average stressed mouse reacted more than about 84 percent of unstressed mice).
  2. The brain change behind it was recruitment, not intensity: 36 versus 24 percent of cells responding, a 49 percent relative increase and 12 points in absolute terms.
  3. The effect was reversible in real time when the circuit was switched off. That hints sensitization is an active, ongoing process and not permanent damage.
  4. The circuit did not drive general anxiety. This supports the idea that heightened reactivity to stressors and background anxiety are separable problems
  5. The implication that limiting severe stress exposure limits later over-reactivity

Context/Source

  • Open Access Paper: An amygdala to anterior hypothalamic circuit gates stress sensitivity
  • Institutions: Nash Family Department of Neuroscience and Department of Pharmacology, Icahn School of Medicine at Mount Sinai, New York; Medical University of South Carolina
  • Country: USA
  • Journal: Nature. published online 30 September 2026.
  • Impact evaluation: The impact score of this journal is 56.1, evaluated against a typical high-end range of 0 to 60+ for top general science, therefore this is an Elite impact journal.

Related Reading:

1 Like
#167

So @relaxedmeatball and others here with kids, how old is old enough for anti-lipid medications? At what age might we want to get our kids on statins or other medications to lower LDL-C / APOB?

See: Nearly 1 in 10 young adults could have fatty, narrow arteries

#168

To my knowledge, guidelines now say 6 years old for those at risk. I’m going through this right now:

I have heterozygous familial hypercholesterolemia (HeFH), so one copy of the allele for high LDL-C, giving me a total LDL-C of 200-220mg/dl. My mother also has it, and her family has a terrible history of early MIs.

I also have high Lp(a) - 60-85mg/dl. Lucky me!

My wife and I tested our first kid: aged 6 her LDL-C was 150, age 7 it was 147, age 8 it was 154, and age 9 her LDL-C jumped to 193mg/dl. The old guidelines said 150mg/dl was the cutoff for children, so she was always around that and so we held off for a while. New guidelines basically recommend treating to adult targets - i.e. 100mg/dl, and her latest test came back at 193mg/dl, so she has started statins (5mg Rosu per day)

Her Lp(a) also came back as 80mg/dl (only tested once, but obviously high). So she got both risk factors from me.

Second kid, tested at age 6, LDL-C 102mg/dl, Lp(a) 64.5mg/dl. So he has normal LDL-C but did they the high Lp(a) from me.

So both of them have elevated risk, with the 9 year old having the highest risk. We’re now doing the trial runs now to see what dosage gives what reduction. If she’s anything like me, statins alone will do nothing. Guidelines also now recommend that kids can also have Ezetimibe. So I think that’s where we will end up; most likely 5mg Rosu + 10mg Ezetimibe per day.

For those at extreme risk (Homozygous FH, LDL-C can be 400mg/dl or higher), I think you can start immediately. Those kids can have other problems like tendonopathy, cholesterol xanthomas and deposits in joints. And they have risk of heart attacks beginning from their teenage years. That’s something a specialist should handle though.

2 Likes
#169

Good feedback. This got me thinking more broadly about what the key blood tests we should be doing on our kids for optimal health and longevity, with a long-term perspective in mind. Here is the prompt, and the result I got from Claude Opus 5.5 below:

Prompt:

System Role: Act as a preventative medicine physician practicing “Medicine 3.0,” leveraging the longevity and healthspan optimization frameworks of Dr. Peter Attia. Your objective is the proactive identification and mitigation of metabolic, cardiovascular, and hormonal disease risk decades before clinical manifestation.

Task: Formulate a prioritized, tiered list of blood tests and biomarkers for 16- and 17-year-old males and females. The primary goal is the early identification of harmful physiological trends to minimize lifetime disease burden.

Output Requirements:

  1. Tiered Prioritization: Categorize the tests into distinct tiers:
    • Tier 1: Essential Baseline & Cardiovascular (e.g., ApoB, Lp(a))
    • Tier 2: Metabolic & Glycemic Control (e.g., Fasting Insulin, Uric Acid, ALT)
    • Tier 3: Sex-Specific Hormonal & Nutritional (e.g., Iron panels, Gonadal hormones)
  2. Sex-Specific Variations: Differentiate the testing priorities and reference ranges for 16/17-year-old males versus females (e.g., the necessity of comprehensive iron/ferritin tracking in menstruating females vs. establishing optimal hormonal baselines in males).
  3. Optimal vs. Normal Ranges: For each biomarker, define the “Medicine 3.0” optimal target range for an adolescent and explicitly contrast it with standard commercial laboratory reference ranges (which represent population averages of a progressively metabolically unhealthy society).
  4. Clinical Rationale & Cumulative Risk: Justify the early measurement of these markers. Specifically address the concept of “area under the curve” (cumulative lifetime exposure) for ApoB and the early pathogenesis of insulin resistance.
  5. Scholarly Debate & Knowledge Gaps: Acknowledge the current limitations and controversies in applying aggressive adult longevity protocols to pediatric populations. Address the lack of longitudinal data on early pharmacological interventions in normolipidemic youth, discuss the debate regarding aggressive lipid-lowering and adolescent neural development, and define what empirical data is currently missing to form a clinical consensus.
  6. Formatting: Deliver the response in strict Markdown format. Use concise, academic prose. Embed URLs to primary source material, pediatric lipid guidelines, or Dr. Attia’s published literature where applicable.

Response from Claude Opus 5.5 below:

Adolescent Biomarker Screening Through a “Medicine 3.0” Lens: A Tiered Protocol for 16–17-Year-Olds

Scope note. The “optimal” targets below are mostly extrapolations. They come from adult Mendelian randomization data, from population percentiles in metabolically healthy youth, and from mechanistic reasoning. Few have been validated against hard outcomes in adolescents, and each table says so. Pediatric guideline cutoffs are cited wherever they exist. Testing a minor also requires age-appropriate consent and shared decision-making that includes the adolescent.

Framing: Why Measure at 16–17?

Late adolescence is a good window for baseline testing for three reasons:

  1. Puberty is mostly finished (typically Tanner 5). The physiological insulin resistance of puberty, which peaks around Tanner 3, has largely resolved, and lipids have recovered from their mid-pubertal dip. Values measured now are close to the person’s adult phenotype.
  2. It is the second universal lipid-screening window (ages 17–21) in the NHLBI Expert Panel guidelines (2011).
  3. Habits are still forming. Lifestyle interventions started here act on the longest possible remaining exposure period.

Tier 1: Essential Baseline & Cardiovascular

Rationale. Atherosclerosis is a disease of cumulative exposure to apoB-containing lipoproteins. It begins in childhood. Autopsy data from PDAY and the Bogalusa Heart Study show fatty streaks and raised lesions in adolescents, and these scale with non-HDL-C and other risk factors.

Biomarker Standard lab / pediatric reference Medicine 3.0 adolescent target Evidence for target
ApoB Adult lab flag usually ~>120–130 mg/dL. NHLBI pediatric: acceptable <90, borderline 90–109, high ≥110 <70 mg/dL (roughly the lower quartile of healthy youth) Extrapolated from MR and adult trial data; no pediatric outcome validation
LDL-C NHLBI: acceptable <110, borderline 110–129, high ≥130. Adult lab: <100 <80–90 mg/dL. LDL ≥160 mg/dL (≥130 with family history) should trigger an FH evaluation FH thresholds are guideline-based (EAS 2015); the optimum is extrapolated
Non-HDL-C NHLBI: acceptable <120, borderline 120–144, high ≥145 <100 mg/dL Extrapolated. Usable non-fasting, which is practical for screening
Triglycerides (ages 10–19) NHLBI: acceptable <90, borderline 90–129, high ≥130 <70 mg/dL. TG/HDL-C ratio <1.5 Ratio is a proxy for insulin resistance; cutoffs vary by ancestry
HDL-C NHLBI: acceptable >45; low <40 >45 (descriptive only, not a target) Raising HDL pharmacologically has no causal benefit
Lp(a) (measure once, report in nmol/L) Labs often flag >30 mg/dL or >75 nmol/L <75 nmol/L (low risk). >125 nmol/L means elevated lifetime risk (EAS 2022) Genetically determined. It rises modestly through childhood, so an adolescent value approximates the adult level
CBC + CMP Standard Within reference range Needed to interpret Tiers 2–3 (iron, liver, renal)
Blood pressure (not a blood test) AAP 2017: ≥13 y, normal <120/<80 <115/75 Essential companion to lipids; cumulative SBP also behaves like an area-under-the-curve exposure

Clinical use of Lp(a). Lp(a) cannot be modified today with approved therapies. Its value is that it sets how aggressively lifetime ApoB should be controlled, and it identifies parents and siblings for cascade screening. A high adolescent Lp(a) is one of the strongest arguments for an early, deliberate lifestyle focus on ApoB.

Area Under the Curve: The ApoB Argument

  • Cumulative exposure model. Atherosclerotic burden scales roughly with concentration × time (often written as “LDL-years”). Untreated homozygous FH reaches the event threshold in childhood. Heterozygous FH reaches it around age 35–45. Typical Western LDL levels reach it in the 50s–60s.
  • Mendelian randomization. Genetic variants that lower LDL for a whole lifetime produce about 2–3× the coronary risk reduction per mmol/L seen in 5-year statin trials (EAS consensus, Ference et al. 2017). Black carriers of PCSK9 loss-of-function variants had about 28% lower LDL-C and about 88% fewer CHD events (Cohen et al., NEJM 2006).
  • Illustrative arithmetic. Holding LDL-C at 80 instead of 110 mg/dL from age 17 to 50 avoids about 1,000 mg/dL-years of exposure, the same burden as several extra decades at a modestly lower level. This is the core logic behind the Attia framework’s preference for early, lifelong suppression of ApoB (Outlive, 2023).
  • Prospective validation. The i3C consortium linked childhood risk factors, including non-HDL-C and triglycerides, to adult cardiovascular events (Jacobs et al., NEJM 2022).

Tier 2: Metabolic & Glycemic Control

Rationale. Hyperinsulinemia and ectopic fat in the liver and muscle precede hyperglycemia by years. HbA1c and fasting glucose are late markers: by the time they become abnormal, a substantial share of β-cell function may already be lost. Youth-onset type 2 diabetes progresses faster than the adult form. TODAY found high rates of complications within about 15 years of diagnosis.

Biomarker Standard lab reference Medicine 3.0 adolescent target Evidence for target
Fasting insulin ~2–25 µIU/mL (assay-dependent) <8 µIU/mL, ideally ~3–6 Distribution-based. Insulin assays are poorly standardized, so trend results within the same lab
Fasting glucose 70–99 mg/dL 70–90 mg/dL Extrapolated from adult cohort data
HbA1c <5.7% (prediabetes 5.7–6.4%) <5.3% Iron deficiency falsely raises A1c, so interpret alongside Tier 3
HOMA-IR (calculated) No standardized pediatric cutoff <1.5–2.0. Values >2.5–3.0 in post-pubertal adolescents suggest insulin resistance Cutoffs vary by population and assay
ALT Many labs use an upper limit of 35–55 U/L Males <25; females <20 U/L. SAFETY upper limits of normal are 26 (M) and 22 (F) NASPGHAN 2017: ALT persistently >2× the SAFETY ULN warrants MASLD evaluation
AST, GGT AST <40; GGT <50–60 GGT <20 U/L Heavy training raises AST and ALT, so avoid testing within 48 h of hard exercise
Uric acid M ~3.5–7.2; F ~2.5–6.0 mg/dL M <5.5; F <4.5 mg/dL Associations with BP, fructose intake, and MASLD; causal role debated
2-h OGTT with insulin (selective) Glucose <140 mg/dL at 2 h Insulin returning toward baseline by 2 h For obesity, family history of T2D, PCOS, or acanthosis; consistent with AAP 2023 obesity CPG

Tier 3: Sex-Specific Hormonal & Nutritional

Females (menstruating)

The main issue in this group is iron deficiency without anemia. It affects roughly 40% of US females aged 12–21 (Weyand et al., JAMA 2023), and a hemoglobin-only screen misses it.

Biomarker Standard lab reference Adolescent target Notes
Ferritin Lower limit often 10–15 ng/mL (WHO deficiency cutoff <15) >50 ng/mL; treat if <30 Ferritin rises with inflammation, so pair with CRP. Recheck every 6–12 months if menses are heavy or the patient is an endurance athlete
TSAT / serum iron / TIBC TSAT 15–50% TSAT 20–45%
Hemoglobin / MCV / RDW Hb ≥12 g/dL Within range A rising RDW is an early sign of iron restriction
TSH, free T4 TSH ~0.5–4.5 mIU/L TSH ~1–2.5 Relevant to menstrual irregularity and fatigue
Hormones (if indicated): total testosterone, SHBG, LH, FSH, estradiol, prolactin Lab-specific Diagnostic use, not “optimization” PCOS in adolescents requires both irregular cycles (>1–2 years post-menarche) and hyperandrogenism. The 2023 international PCOS guideline advises against ultrasound or AMH for diagnosis within 8 years of menarche. Athletes with amenorrhea need evaluation for RED-S / functional hypothalamic amenorrhea

Males

Biomarker Standard lab reference Adolescent target Notes
Total testosterone (fasting, before 10 a.m.) Tanner 5 range about 300–1,000+ ng/dL Baseline documentation, not a target The main value is a lifelong comparison point and detection of obesity-related hypogonadism
SHBG, calculated free T, LH, FSH, estradiol Lab-specific Coherent axis Suppressed LH/FSH with high testosterone or high hematocrit suggests exogenous androgen use, which is a real and underappreciated problem in this age group
Hematocrit ~39–50% <50%
Ferritin / TSAT Ferritin ~30–300 Ferritin 50–150; TSAT <45% TSAT >45% warrants HFE testing. Endurance athletes can become depleted

Both sexes (selective)

  • 25-OH vitamin D. The Endocrine Society 2024 guideline recommends empiric supplementation for ages 1–18 and against routine testing in healthy people. This is a direct conflict with longevity-clinic practice.
  • B12 and folate for vegetarian or vegan adolescents.
  • Omega-3 index (target ≥8%). Popular in the Attia framework, but outcome data in youth are lacking.
  • hs-CRP. Low yield in adolescents and easily confounded by intercurrent infection. Use it mainly to interpret ferritin.

Scholarly Debate & Knowledge Gaps

1. Screening itself is contested

  • NHLBI/AAP recommend universal lipid screening at ages 9–11 and 17–21.
  • The USPSTF (2023) gives an “I” statement (insufficient evidence) for lipid screening in asymptomatic youth (JAMA 2023). It cites the lack of trials linking pediatric screening to adult outcomes.
  • Real-world uptake of universal screening is low. FH, the clearest beneficiary (prevalence about 1 in 250), stays largely undiagnosed until adulthood.

2. Pharmacotherapy evidence is confined to FH

  • The strongest data come from children with heterozygous FH. In 20-year follow-up, statin therapy started in childhood was associated with fewer cardiovascular events than in affected parents, and no growth or pubertal harms appeared (Luirink et al., NEJM 2019). Evolocumab was effective in pediatric HeFH in HAUSER-RCT (Santos et al., NEJM 2020).
  • There are no randomized or long-term cohort data on lipid-lowering drugs in normolipidemic adolescents. Extending Medicine 3.0’s “lower for longer” logic to drug treatment in a 16-year-old with LDL 110 mg/dL is hypothesis, not evidence. For non-FH youth, the defensible current position is measurement plus lifestyle.

3. Lipid lowering and neural development

  • Concern. Myelination and synaptic pruning continue into the mid-20s, and myelin is cholesterol-rich.
  • Counterpoints. Brain cholesterol is synthesized locally, and circulating LDL does not cross the blood–brain barrier. PCSK9 antibodies do not enter the CNS. Hydrophilic statins (rosuvastatin, pravastatin) penetrate less than lipophilic ones. Lifelong low LDL from PCSK9 loss-of-function variants shows no neurocognitive phenotype.
  • Caveats. Pediatric FH trials were not powered for subtle cognitive or psychiatric outcomes. Severe hypobetalipoproteinemia does cause neurological disease, though mainly through fat-soluble vitamin malabsorption, which is a different mechanism. For adolescent females, statins are still generally stopped before conception, which complicates long-horizon therapy.

4. Harms of “optimization” culture in adolescents

  • Over-interpreting borderline results can label healthy teens, drive anxiety, and push toward restrictive eating. Adolescents have the highest incidence of eating disorders, so framing matters.
  • Hormonal “optimization” language is especially risky for adolescent males, given their access to androgens and SARMs. Hormone testing at this age should be diagnostic and protective, not aspirational.

5. What empirical data are missing for a consensus

  1. Outcome-anchored pediatric thresholds for ApoB, fasting insulin, ALT, and Lp(a), as opposed to percentile-derived ones.
  2. Long-term cohorts connecting adolescent ApoB and insulin trajectories to imaging (CAC, CCTA plaque in the 30s–40s) and to events.
  3. Pragmatic trials testing whether disclosing biomarkers to adolescents changes long-term behavior and outcomes, including psychological effects.
  4. Assay standardization for insulin and Lp(a) (nmol/L, isoform-insensitive methods).
  5. Safety data on CNS and endocrine outcomes for any lipid-lowering class started before age 25 in people without FH.
  6. Cost-effectiveness modeling of universal versus risk-based panels, beyond FH detection.

Summary Priority List

Priority Males (16–17) Females (16–17)
Tier 1 ApoB, lipid panel, Lp(a) once, CBC, CMP, BP Same
Tier 2 Fasting insulin, glucose, HbA1c, HOMA-IR, ALT/GGT, uric acid; OGTT if risk factors Same; interpret HbA1c alongside iron status
Tier 3 AM total T, SHBG, LH/FSH (baseline and androgen-misuse screen); ferritin/TSAT Ferritin, TSAT, CBC indices (high priority); TSH; androgens/LH/FSH only if PCOS or amenorrhea is suspected
#170

I agree with most of that in principle. However, I think we also need to consider that a 16-17 year old should be having their own life, and subjecting them to a battery of medical tests is something you probably want to be careful with. There’s a balancing act IMO between recognising and dealing with problems early, and making them have some sort of pathogenic health anxiety issues. As we know, eating disorders, body dysmorphia etc are prevalent. I can imagine negative consequences if you start emphasising optimisation to teenagers who are just trying to find their independence, and already have enough to deal with from the Manosphere and crazy influencers telling them they need to look a certain way.

For me personally, I would still prefer to be symptom-led for a lot of those. For example, if your 16-17 year is active, fit, eats appropriately etc, there’s no real reason to be worrying about their HBA1C, fasting insulin etc. There’s almost no chance they would be pre-diabetic. And, if they are unfortunately obese, or skinny-fat, inactive and drink 8 cokes a day, you have a very obvious problem that doesn’t really require a blood test before you take action.

The case of FH is different, since it is lifelong, completely out of the persons control, and not modifiable by lifestyle. So medicating it is really the only sensible option.

For kids, I would be really prioritising sleep, establishing good dietary patterns, establishing good habits of activity and exercise. (Other people drive their kids the 5 mins to school. We walk every day, climb the hill to our house most days. I take stairs if it’s less than 3 floors. Things like that.)

From what I’ve heard, anemia and bone density are two critical issues - but again, they’re quite reasonably addressed through very simple lifestyle practices. So if I have an otherwise healthy 16 year old who has stayed doing her gymnastics, drinking milk etc, I’m not really thinking she needs a DEXA scan.

Hope that makes sense.

1 Like